A 5‐year longitudinal follow‐up study of serological responses to 23‐valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy

Background Long‐term antibody responses to 23‐valent pneumococcal polysaccharide vaccine (PPV) among HIV‐infected patients receiving highly active antiretroviral therapy (HAART) are rarely investigated. Methods Antibody responses to three pneumococcal capsular polysaccharides [Pneumococcal polysacch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2010-01, Vol.11 (1), p.54-63
Hauptverfasser:	Hung, C‐C, Chang, S‐Y, Su, C‐T, Chen, Y‐Y, Chang, S‐F, Yang, C‐Y, Liu, W‐C, Wu, C‐H, Chang, S‐C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Bacterial - blood antibody response Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Female Follow-Up Studies HIV HIV Infections - drug therapy HIV Infections - immunology Human immunodeficiency virus Humans Longitudinal Studies Male Middle Aged Pneumococcal Infections - immunology Pneumococcal Infections - prevention & control pneumococcal polysaccharide vaccine pneumococcal vaccination Pneumococcal Vaccines - immunology Pneumococcal Vaccines - therapeutic use RNA, Viral - blood Streptococcus pneumoniae Streptococcus pneumoniae - immunology Treatment Outcome Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!